CD4 and neoplasm: In addition, SLC1A5 expression was positively correlated with the number of tumor-infiltrating B cells, CD4+ T cells, CD8+ T cells, macrophages, neutrophils, and dendritic cells in HCC and low-grade glioma (LGG), indicating its role in regulating tumor immunity [140].